Underwriting

Lycos Energy Inc. Announces Strategic Acquisition of Durham Creek Exploration Ltd. and $25 Million Equity Financing

Retrieved on: 
Wednesday, September 13, 2023
LLP, NOT, TSX Venture Exchange, FOR, SEC Rule 144A, GP, Stikeman Elliott, Swimming, Underwriting, Public expenditure, IP30, Prospectus, WIRE, Duckworth, Offering, NEWS, WTI, WCS, Court of King's Bench of Alberta, DCEL, Rex, Oil, Fine chemical, Airline, Sales, Security (finance), Financial services, Insurance, Lycos, Acquisition

CALGARY, Alberta, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Lycos Energy Inc. ("Lycos" or the "Company") (TSXV: LCX) is pleased to announce that it has entered into a definitive agreement (the "Acquisition Agreement") today to acquire Durham Creek Exploration Ltd. ("DCEL"), a privately-held, arm's length, heavy oil producer, by way of a plan of arrangement for total consideration, prior to adjustments, of $22.5 million (the "Acquisition"), consisting of $12.5 million in cash and 2.8 million common shares of Lycos (“Lycos Shares”) at a deemed price of $3.55 per Lycos Share.

Key Points: 
  • Increases Tier 1 Mannville inventory (Rex, Waseca, GP and Cummings) by 77% to 55 total net locations.
  • Tier 1 locations have an expected payout period of less than 6 months and an NPV-10% of $5.5 million(1).
  • National Bank Financial Inc. is acting as exclusive financial advisor to Lycos with respect to the Acquisition.
  • Stikeman Elliott LLP is acting as legal counsel to Lycos with respect to the Acquisition and the Offering.

Azimut Announces $8 Million Bought Deal Private Placement Financing

Retrieved on: 
Wednesday, September 13, 2023
Cloud, Exercise, FT, AEM, Section 50C of the Isle of Man Income Tax Act 1970, Critical, Hard, Underwriting, Oil Taxation Act 1975, Sale, Offering, Income Tax Act, TSX, Agnico Eagle, Wainwright Securities Inc. v. Wall Street Transcript Corp., Life insurance, Security (finance)

LONGUEUIL, Quebec, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (TSXV: AZM) (OTCQX: AZMTF) (“Azimut” or the “Company”) is pleased to announce that it has entered into an agreement with Paradigm Capital Inc. on behalf of a syndicate of underwriters, including Red Cloud Securities Inc. (collectively, the “Underwriters”), in connection with a bought deal private placement financing (the “Offering”) for total proceeds of $8,000,000, consisting of 2,442,100 common shares of the Company that qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada) and section 359.1 of the Taxation Act (Québec)) (the “Premium FT Shares”) at a price of $2.0475 per Premium FT Share, 550,600 common shares of the Company that qualify as “flow-through shares” (within the meaning of subsection 66(15) of the Income Tax Act (Canada) and section 359.1 of the Taxation Act (Québec)) (the “FT Shares”) at a price of $1.8165 per FT Share, and 1,904,800 common shares of the Company (the “Hard Dollar Shares”) at a price of $1.05 per Hard Dollar Share (the “Hard Dollar Issue Price”).

Key Points: 
  • The term “Offering” includes the additional Hard Dollar Shares that may be issued on the exercise of the Underwriters’ Option, if any.
  • The proceeds from the sale of the Hard Dollar Shares will be used for exploration and for general corporate purposes.
  • Closing is expected to occur on or about September 28, 2023, or other such dates as the Company and the Underwriters may agree (the “Closing Date”).
  • The securities have not been, and will not be, registered under the Unites States Securities Act of 1933, as amended (the “U.S.

DRI Healthcare Trust Announces C$90 Million Bought Deal Public Offering of Units

Retrieved on: 
Tuesday, September 12, 2023
Unit, Treasury, NOT, FOR, Toronto Stock Exchange, Trust, Underwriting, Sale, RBC Capital Markets, Prospectus, Offering, TSX, Scotiabank, Security (finance)

TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announced today that it has entered into an agreement with a syndicate of underwriters led by Scotiabank, CIBC Capital Markets and RBC Capital Markets (collectively, the “Underwriters”), pursuant to which the Trust will issue from treasury, and the Underwriters will purchase on a “bought deal” basis, 8,200,000 units (the “Units”) of the Trust, at a price of C$11.00 per Unit (the “Offering Price”) for gross proceeds of approximately C$90.2 million (the “Offering”).

Key Points: 
  • The Trust has granted the Underwriters an option (the “Over-Allotment Option”), exercisable in whole or in part, at any time for a period of 30 days from the closing of the Offering, to purchase from the Trust up to an additional 1,230,000 Units at the Offering Price, for additional gross proceeds of approximately C$13.5 million.
  • The Trust intends to use the net proceeds of the Offering to fund its near term pipeline of royalty transactions.
  • The Trust is currently in various stages of negotiations and due diligence with counterparties on several potential royalty transactions that would meet its transaction criteria.
  • Closing of the Offering is expected to occur on or about September 20, 2023, subject to customary conditions including the approval of applicable securities regulatory authorities and the Toronto Stock Exchange.

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

Retrieved on: 
Tuesday, September 5, 2023
Unit, Indian stock exchange, Toronto Stock Exchange, Person, Sale, Underwriting, Date, National instrument, Offering, TSX, Security (finance)

Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”).

Key Points: 
  • Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”).
  • Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of C$3.65 at any time up to 30 months following the Closing Date (as defined below).
  • The net proceeds of the Offering will be used for working capital and general corporate purposes.
  • Securities Act”), and applicable U.S. state securities laws.

F3 Announces Revised Bought Deal Private Placement for Gross Proceeds of C$17.5 Million

Retrieved on: 
Tuesday, August 15, 2023
Cloud, Indian stock exchange, FUU, Income Tax Act 1967, Uranium, Athabasca Basin, Underwriting, Sale, Prospectus, Date, National instrument, Offering, Income Tax Act, Multilateral, Security (finance)

Red Cloud Securities Inc. is acting as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the "Underwriters").

Key Points: 
  • Red Cloud Securities Inc. is acting as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the "Underwriters").
  • The Company has also increased the potential size of the Over-Allotment Option (as defined herein) from C$2,250,000 to C$2,500,000.
  • If the Over-Allotment Option is exercised in full, the total gross proceeds of the Offering will be C$20,000,000.
  • The proceeds of the Offering will be used by the Company to fund exploration of the Company's projects in the Athabasca Basin.

F3 Announces C$15 Million Bought Deal Private Placement

Retrieved on: 
Monday, August 14, 2023
Cloud, Indian stock exchange, FUU, Income Tax Act 1967, Uranium, Athabasca Basin, Underwriting, Sale, Prospectus, Date, National instrument, Offering, Income Tax Act, Wainwright Securities Inc. v. Wall Street Transcript Corp., Multilateral, Security (finance)

The FT Shares will be issued as charitable flow-through common shares of the Company.

Key Points: 
  • The FT Shares will be issued as charitable flow-through common shares of the Company.
  • The Offering is expected to close on September 12, 2023 (the "Closing Date").
  • The Company will pay to the Underwriters a cash commission of 5.5% of the gross proceeds raised in respect of the Offering (the "Underwriters' Commission").
  • The proceeds of the Offering will be used by the Company to fund exploration of the Company's projects in the Athabasca Basin.

Exro Technologies Announces Second Quarter 2023 Financial Results

Retrieved on: 
Friday, August 11, 2023
DFM, Exercise, Interim, Letter, Indian stock exchange, Partnership, Marketing, Electronics, Linamar, Torque, AB, NDA, Telephone numbers in South Africa, Research, Vicinity Motor Corp., Distribution (marketing), Southwestern United States, Underwriting, UL, Certification, Zenith Contract Services, US, Traction, Party, UL (safety organization), Coil, HB4, Engineering, Cell, Solar energy, TSX, Depreciation, OEM, LINK, Clothing, Renewable energy, Electric motor, Rail transport, Q3, European

CALGARY, AB, Aug. 10, 2023 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean technology company which has developed a new generation power control electronics that expand the capabilities of electric motors and batteries, announced today its financial results for the quarter ended June 30, 2023.

Key Points: 
  • CALGARY, AB, Aug. 10, 2023 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean technology company which has developed a new generation power control electronics that expand the capabilities of electric motors and batteries, announced today its financial results for the quarter ended June 30, 2023.
  • "The second quarter of 2023 demonstrated continued progress towards commercialization of our next generation technologies for electric vehicles and stationary energy storage", said Exro CEO Sue Ozdemir.
  • In Q1 2023, Exro announced signing a partnership with a global European-based tier-1 OEM automotive supplier.
  • In Q2 2023, Exro announced signing the world's third largest motor manufacturer, Wolong Electric Group, as a strategic partner.

GMG Announces Pricing of Marketed Unit Offering

Retrieved on: 
Thursday, August 10, 2023
Unit, Indian stock exchange, The Supplement, GMG, Research, Underwriting, Sale, Warrant, Prospectus, Offering, Supplement, Security (finance)

BRISBANE, Australia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce pricing of its previously announced marketed offering (the "Offering") of units (the "Units") of the Company.

Key Points: 
  • BRISBANE, Australia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce pricing of its previously announced marketed offering (the "Offering") of units (the "Units") of the Company.
  • Pursuant to the Offering, the Company will issue 1,764,706 Units at a price of $1.70 per Unit for aggregate gross proceeds to the Company of approximately $3 million.
  • Each Unit will consist of one ordinary share of the Company (a "Common Share") and one-half of one ordinary share purchase warrant (each whole ordinary share purchase warrant, a "Warrant").
  • The Supplement and the Base Shelf Prospectus contain important detailed information about the Company and the proposed Offering.

GMG Announces Marketed Unit Offering

Retrieved on: 
Wednesday, August 9, 2023
Exercise, Indian stock exchange, TSX Venture Exchange, GMG, Research, Attention, Underwriting, Sale, Prospectus, Offering, Post office box, Supplement, Security (finance), Unit, Warrant

BRISBANE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce that it is commencing a marketed offering (the "Offering") of units (the "Units") of the Company. Each Unit will consist of one ordinary share of the Company (a "Common Share") and one-half of one ordinary share purchase warrant (each whole ordinary share purchase warrant, a "Warrant").

Key Points: 
  • BRISBANE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce that it is commencing a marketed offering (the "Offering") of units (the "Units") of the Company.
  • There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
  • Each Compensation Warrant shall entitle the Underwriters to purchase one Unit at the Offering Price at any time on or before the date which is 36 months following closing of the Offering.
  • The Supplement and the Base Shelf Prospectus contain important detailed information about the Company and the proposed Offering.

Oncolytics Biotech® Successfully Raises US$15 Million to Advance Breast and Pancreatic Cancer Clinical Programs

Retrieved on: 
Tuesday, August 8, 2023
Acceleration, Closing, Indian stock exchange, Oncolytics Biotech, Bookrunner, Bank statement, Equity, Person, Sale, Underwriting, Prospectus, ONC, National instrument, Offering, TSX, News, Security (finance), Warrant

CALGARY, Alberta, Aug. 8, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (NASDAQ: ONCY) (TSX: ONC) today announced the closing (the "Closing") of the previously announced underwritten public offering of US$15,000,750 (the "Offering").

Key Points: 
  • CALGARY, Alberta, Aug. 8, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (NASDAQ: ONCY) (TSX: ONC) today announced the closing (the "Closing") of the previously announced underwritten public offering of US$15,000,750 (the "Offering").
  • An institutional investor was a significant participant in the Offering.
  • The Company intends to use the proceeds from the Offering to continue the advancement of its pelareorep clinical programs in metastatic breast and pancreatic cancers, as well as general corporate and working capital purposes.
  • Each Equity Unit consists of one common share of the Company (each a "Common Share") and one Common Share purchase warrant (each a "Warrant").